These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 23180585)

  • 1. Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF.
    Weyer K; Mirzayev F; Migliori GB; Van Gemert W; D'Ambrosio L; Zignol M; Floyd K; Centis R; Cirillo DM; Tortoli E; Gilpin C; de Dieu Iragena J; Falzon D; Raviglione M
    Eur Respir J; 2013 Jul; 42(1):252-71. PubMed ID: 23180585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the Xpert MTB/RIF assay for diagnosis of tuberculosis with gastric lavage aspirates in children in sub-Saharan Africa: a prospective descriptive study.
    Bates M; O'Grady J; Maeurer M; Tembo J; Chilukutu L; Chabala C; Kasonde R; Mulota P; Mzyece J; Chomba M; Mukonda L; Mumba M; Kapata N; Rachow A; Clowes P; Hoelscher M; Mwaba P; Zumla A
    Lancet Infect Dis; 2013 Jan; 13(1):36-42. PubMed ID: 23134697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid molecular detection of pulmonary tuberculosis in HIV-infected patients in Santiago, Chile.
    Balcells ME; García P; Chanqueo L; Bahamondes L; Lasso M; Gallardo AM; Cifuentes L
    Int J Tuberc Lung Dis; 2012 Oct; 16(10):1349-53. PubMed ID: 22863872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosing pulmonary tuberculosis with the Xpert MTB/RIF test.
    Bodmer T; Ströhle A
    J Vis Exp; 2012 Apr; (62):e3547. PubMed ID: 22508485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Xpert MTB/RIF assay at a tertiary care referral hospital in a setting where tuberculosis and HIV infection are highly endemic.
    O'Grady J; Bates M; Chilukutu L; Mzyece J; Cheelo B; Chilufya M; Mukonda L; Mumba M; Tembo J; Chomba M; Kapata N; Maeurer M; Rachow A; Clowes P; Hoelscher M; Mwaba P; Zumla A
    Clin Infect Dis; 2012 Nov; 55(9):1171-8. PubMed ID: 22806590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of replacing smear microscopy with Xpert MTB/RIF for diagnosing tuberculosis in Brazil: a stepped-wedge cluster-randomized trial.
    Durovni B; Saraceni V; van den Hof S; Trajman A; Cordeiro-Santos M; Cavalcante S; Menezes A; Cobelens F
    PLoS Med; 2014 Dec; 11(12):e1001766. PubMed ID: 25490549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysis.
    Pantoja A; Fitzpatrick C; Vassall A; Weyer K; Floyd K
    Eur Respir J; 2013 Sep; 42(3):708-20. PubMed ID: 23258774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of Xpert MTB/RIF for routine point-of-care diagnosis of tuberculosis at the primary care level.
    Clouse K; Page-Shipp L; Dansey H; Moatlhodi B; Scott L; Bassett J; Stevens W; Sanne I; Van Rie A
    S Afr Med J; 2012 Sep; 102(10):805-7. PubMed ID: 23034211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xpert MTB/RIF assay for diagnosis of pulmonary tuberculosis in children: a prospective, multi-centre evaluation.
    Reither K; Manyama C; Clowes P; Rachow A; Mapamba D; Steiner A; Ross A; Mfinanga E; Sasamalo M; Nsubuga M; Aloi F; Cirillo D; Jugheli L; Lwilla F
    J Infect; 2015 Apr; 70(4):392-9. PubMed ID: 25312863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of Xpert MTB/RIF results for the detection of Mycobacterium tuberculosis in clinical samples].
    Ciftçi IH; Aslan MH; Aşık G
    Mikrobiyol Bul; 2011 Jan; 45(1):43-7. PubMed ID: 21341158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of the Xpert® MTB/RIF assay for tuberculosis diagnosis in Brazil.
    Pinto M; Steffen RE; Cobelens F; van den Hof S; Entringer A; Trajman A
    Int J Tuberc Lung Dis; 2016 May; 20(5):611-8. PubMed ID: 27084814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xpert® MTB/RIF for national tuberculosis programmes in low-income countries: when, where and how?
    Trébucq A; Enarson DA; Chiang CY; Van Deun A; Harries AD; Boillot F; Detjen A; Fujiwara PI; Graham SM; Monedero I; Rusen ID; Rieder HL
    Int J Tuberc Lung Dis; 2011 Dec; 15(12):1567-72. PubMed ID: 22005110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: a meta-analysis.
    Chang K; Lu W; Wang J; Zhang K; Jia S; Li F; Deng S; Chen M
    J Infect; 2012 Jun; 64(6):580-8. PubMed ID: 22381459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. False-positive rifampin resistant results with Xpert MTB/RIF version 4 assay in clinical samples with a low bacterial load.
    Ocheretina O; Byrt E; Mabou MM; Royal-Mardi G; Merveille YM; Rouzier V; Fitzgerald DW; Pape JW
    Diagn Microbiol Infect Dis; 2016 May; 85(1):53-5. PubMed ID: 26915638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Feasibility of Xpert MTB/RIF Testing to Detect Rifampicin Resistance among Childhood Tuberculosis for Prevalence Surveys in Northern China.
    Lu J; Li H; Dong F; Shi J; Yang H; Han S; Chu P; Zhao Y; Song W; Guo Y; Zhao S
    Biomed Res Int; 2017; 2017():5857369. PubMed ID: 29359155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pre-clinical validation plan to evaluate analytical sensitivities of molecular diagnostics such as BD MAX MDR-TB, Xpert MTB/Rif Ultra and FluoroType MTB.
    Beutler M; Plesnik S; Mihalic M; Olbrich L; Heinrich N; Schumacher S; Lindner M; Koch I; Grasse W; Metzger-Boddien C; Hofmann-Thiel S; Hoffmann H
    PLoS One; 2020; 15(1):e0227215. PubMed ID: 31910223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of Xpert® MTB/RIF depends on service coordination: experience in Burkina Faso.
    Moyenga I; Roggi A; Sulis G; Diande S; Tamboura D; Tagliani E; Castelli F; Matteelli A
    Int J Tuberc Lung Dis; 2015 Mar; 19(3):285-7. PubMed ID: 25686135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test.
    Lawn SD; Mwaba P; Bates M; Piatek A; Alexander H; Marais BJ; Cuevas LE; McHugh TD; Zijenah L; Kapata N; Abubakar I; McNerney R; Hoelscher M; Memish ZA; Migliori GB; Kim P; Maeurer M; Schito M; Zumla A
    Lancet Infect Dis; 2013 Apr; 13(4):349-61. PubMed ID: 23531388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xpert MTB/RIF test for tuberculosis.
    Ferrara G; O'Grady J; Zumla A; Maeurer M
    Lancet; 2011 Aug; 378(9790):482; author reply 482-3. PubMed ID: 21821179
    [No Abstract]   [Full Text] [Related]  

  • 20. Rapid molecular tests for tuberculosis and tuberculosis drug resistance: a qualitative evidence synthesis of recipient and provider views.
    Engel N; Ochodo EA; Karanja PW; Schmidt BM; Janssen R; Steingart KR; Oliver S
    Cochrane Database Syst Rev; 2022 Apr; 4(4):CD014877. PubMed ID: 35470432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.